Legg Mason Asset Management’s United Therapeutics UTHR Stock Holding History

Legg Mason Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$848K	Sell	3,924 -196	-5%	-$38.5K	0.94%	38
2021 Q3	$760K	Buy	4,120 +1,230	+43%	+$242K	0.88%	45
2021 Q2	$518K	Sell	2,890 -258	-8%	-$49.1K	0.57%	90
2021 Q1	$527K	Buy	+3,148	New	+$525K	0.57%	95
2017 Q2	–	Sell	-4,200	Closed	-$569K	–	134
2017 Q1	$569K	Sell	4,200 -400	-9%	-$60.6K	0.66%	80
2016 Q4	$660K	Sell	4,600 -800	-15%	-$102K	0.75%	72
2016 Q3	$638K	Hold	5,400	–	–	0.64%	81
2016 Q2	$572K	Sell	5,400 -100	-2%	-$11.2K	0.61%	88
2016 Q1	$613K	Buy	+5,500	New	+$696K	0.63%	87

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Legg Mason Asset Management's UTHR Position: Q4 2021 in Review

Legg Mason Asset Management reduced its United Therapeutics (UTHR) stake by 4.8% in Q4 2021, selling an estimated $38.5K and leaving 3,924 shares worth $848K. The position accounts for 0.94% of the portfolio, ranked #38.

Legg Mason Asset Management first reported a position in UTHR in Q1 2016 and has held it in 9 quarters since. 416 funds tracked by Wall St. Rank hold UTHR as of Q4 2021.

Legg Mason Asset Management held 3,924 shares of United Therapeutics worth $848K as of Q4 2021.
Legg Mason Asset Management sold 196 United Therapeutics shares in Q4 2021, an estimated $38.5K.
United Therapeutics made up 0.94% of Legg Mason Asset Management's portfolio in Q4 2021, its #38 holding.
Legg Mason Asset Management first reported a position in United Therapeutics in Q1 2016 and has held it in 9 quarters since.
416 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2021.

Based on Legg Mason Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.